Sep 16 2013
Masimo today announced that Rochester General Health System and its 528-bed flagship Rochester General Hospital have installed the Masimo Patient SafetyNet™ system, a remote monitoring and clinician notification system shown to dramatically reduce rapid response activations, transfers to intensive care units, and deaths related to opioid-induced respiratory depression.
Rochester General joins a growing list of prominent health systems around the world using Patient SafetyNet, which combines the performance of Masimo SET® pulse oximetry, the enabler of reliable monitoring in the general ward, with ventilation monitoring and wireless clinician notification. Patient SafetyNet can can help ensure patients' safety by noninvasively and continuously measuring and tracking their underlying physiological conditions and changes that signal declining health status in real-time. When changes occur in the measured values, which may indicate deterioration in the patient's condition, the system automatically sends wireless alerts directly to clinicians – prompting a potentially lifesaving response to the patient's bedside.
"Masimo provides us with the advanced technologies we need to meet our high standards for patient care," said Claire Aloan, MS, RRT-NPS, FAARC, Director of Respiratory Care Services for the Rochester General Health System. "Patient SafetyNet offers us the ability to respond to patients faster. And Masimo SET® pulse oximetry – because of its clinical accuracy – gives us confidence that we're responding to true alarms. This speed and accuracy allows us to improve patient outcomes
The installation at Rochester General Hospital took place after an extensive evaluation process resulting in the organization's standardization to Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry. The performance of Masimo SET® pulse oximetry is proven by more than 100 independent and objective studies and thousands of clinical evaluations. Masimo SET® is trusted by clinicians to safely monitor more than 100 million patients each year and is used hospital-wide by eight of the top 10 hospitals on the U.S. News & World Report Best Hospitals Honor Roll (2013-2014). Compared to other pulse oximeters during patient motion and low perfusion, Masimo SET® provides measurements when other pulse oximeters cannot, dramatically reduces false alarms (specificity), and accurately detects true alarms (sensitivity) that can indicate a deteriorating patient. Most importantly, Masimo SET® pulse oximetry has been shown to improve patient outcomes by helping clinicians reduce retinopathy of prematurity (ROP) in neonates, screen newborns for critical congenital heart disease (CCHD), reduce ventilator weaning time and arterial blood gas measurements in the ICU, and save lives and costs while reducing rapid response activations and intensive care unit transfers on the general floor.
Source: http://www.masimo.com/